Pharmaceutical Regulatory Affairs Consulting
China and the Asia Pacific region represent significant opportunities for life sciences companies, but accessing these key markets but accessing these key markets demands a deep understanding of regulatory systems and a clear, sound regulatory strategy.
From shifting requirements and language-specific submissions regulatory agencies and regulatory changes, the region’s frameworks present both promise and potential challenges. At Cisema, we help pharmaceutical companies move forward with confidence by offering expert regulatory affairs consulting tailored to China and the wider Asia Pacific region.
We support your regulatory journey with end-to-end solutions, from early-stage clinical trial applications to post-market lifecycle management. Our services are built on decades of experience, strong local presence, and close engagement with national regulatory authorities. Whether you are preparing for drug application to the NMPA in China or navigating review processes across ASEAN, South Korea, Japan, or Australia, we help reduce approval risk, align with local requirements, and accelerate successful market entry.
Breaking into APAC markets requires more than global documentation, it requires regional adaptation, regulatory intelligence, and operational precision. Our team of experienced regulatory professionals, including expert regulatory consultants, works closely with pharmaceutical and biotech clients to design sound regulatory strategies, ensure compliance, and deliver smoother approval pathways. We simplify your route to product approvals, so you can focus on bringing breakthrough therapies and biologics to patients across the region.
Our Pharmaceutical Regulatory Affairs Services in China & Asia Pacific
Regulatory Strategy & Planning
We assess your product’s regulatory requirements in China and across key Asia Pacific markets and develop submission strategies aligned with local authority expectations. Our customized roadmaps reduce approval delays and help mitigate compliance risks from the outset.
Dossier Preparation & Submission Management
From (Pre-)INDs, CTAs, NDAs, BLAs to DMFs, our regulatory consultants manage the full cycle of pharmaceutical submissions. We handle dossier preparation and formatting to meet both local and global regulatory standards, coordinating directly with regulatory agencies to facilitate a smooth, transparent review process.
CMC Support & GMP Alignment
Chemistry, Manufacturing, and Controls (CMC) compliance is critical for approval. We assist with CMC documentation, GMP expectations, technology transfer, and regulatory gap analysis to meet authority requirements and support manufacturing readiness.
Agency Communication & Representation
We serve as your liaison with regulatory authorities and regulatory agencies in China and across Asia Pacific. From managing pre-submission meetings to handling deficiency responses and advisory consultations, we ensure clear, consistent communication to support timely decision-making.
Labeling & Promotional Compliance
We review and localize your product labeling, packaging, and promotional content to meet country-specific regulatory guidelines. Our support ensures compliance with language, content, and format standards across diverse markets.
Local Representation (Legal Agent / Domestic Responsible Agent)
As required in many jurisdictions, we act as your in-country regulatory representative. Our team manages submissions, post-market compliance, and authority communications, offering peace of mind without the need to establish a local legal entity.
Why Work with Cisema?
Local expertise with global reach
Our bilingual teams bridge international quality standards with local regulations
Proven track record
Over 20 years supporting market approvals and compliance in China and Asia Pacific
End-to-end solutions
From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle
Industry breadth
Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods
Frequently Asked Questions
Ideally, during early development. Early regulatory planning allows for better alignment with local data requirements and smoother submission timelines.
While some systems are harmonizing globally, each APAC country has unique processes, especially around dossier format, language, clinical data, and post-market expectations. We guide you through these distinctions to ensure compliance.
In many cases, yes, with caveats. China and other jurisdictions may require bridging or local studies. We evaluate your evidence and advise on the most efficient approval pathways.
We conduct a root cause analysis and engage with authorities to resolve issues quickly. Our team provides corrective strategies to get your application back on track.
Many jurisdictions, including China, South Korea, and Thailand, require local representation. Cisema acts as your regulatory agent across the region, managing compliance and authority interactions.
Our regulatory affairs experts support a full range of pharmaceutical submissions, from (Pre-)INDs, CTAs, NDAs, BLAs, to DMFs, from small molecules to biologics, and across all stages of development throughout the market lifecycle.
Request a Proposal from Our Pharma Team
Let Cisema help turn your plans into reality.
Explore Related Services
Pharmaceutical Development & Strategy
Drive successful market entry and growth with confidence. Our pharmaceutical consulting experts support biotech and life sciences companies in streamlining drug development, accelerating approvals, and achieving commercialization through tailored strategies, clinical insights, and end-to-end compliance solutions.
Health Economics & Market Access
Accelerate access across China and Asia Pacific with confidence. Our market access consulting experts help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.
Pharmacovigilance
Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.
Quality Management & Compliance
Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences companies strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.
